Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 6, Issue 8 (2017)

Value of C‐reactive protein and the type IV collagen measurement in patients with severe COPD

Author(s):
Kseniia Ostrovska, Iryna Savelikhina, Mykola Ostrovskyy, Oleksandr Varunkiv, Mariana Kulynych-Miskiv and Nataliia Ivanyshyn
Abstract:
The burden of chronic obstructive pulmonary disease (COPD) is considerable, both socially and economically. In many countries, COPD prevalence is directly related to the prevalence of tobacco smoking. Alternate risk factors to cigarette smoke include exposure to occupational dusts and chemicals, and indoor pollution from biomass fuels. Patients with COPD have an ongoing systemic inflammation, which can be assessed by measuring serum C-reactive protein (CRP).
Pages: 06-08  |  1552 Views  94 Downloads


The Pharma Innovation Journal
How to cite this article:
Kseniia Ostrovska, Iryna Savelikhina, Mykola Ostrovskyy, Oleksandr Varunkiv, Mariana Kulynych-Miskiv, Nataliia Ivanyshyn. Value of C‐reactive protein and the type IV collagen measurement in patients with severe COPD. Pharma Innovation 2017;6(8):06-08.

Call for book chapter